Bioseutica B.V.
Records under this name other than the patents Bioseutica B.V. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.
Showing 1 to 6 of 6 · Back to Bioseutica B.V.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,553,870 | Use of polyunsaturated fatty acid for the primary prevention of major cardiovascular events Term ended Term ended Sep 14, 2024 · USPTO record | Term ended | Term ended Sep 14, 2024 | USPTO record |
| US 8,119,600 | Compositions containing lysozyme and C-1/C-4 polysaccharides and use thereof in oral care, cosmetology and dermatology, contraception, urology and gynecology Lapsed on the fee record Ended Feb 21, 2024 · USPTO record | Lapsed on the fee record | Ended Feb 21, 2024 | USPTO record |
| US 8,648,061 | Use of polyunsaturated fatty acids for the primary prevention of major cardiovascular events Lapsed on the fee record Ended Feb 11, 2022 · USPTO record | Lapsed on the fee record | Ended Feb 11, 2022 | USPTO record |
| US 7,619,002 | Use of polyunsaturated fatty acids for the primary prevention of major cardiovascular events Lapsed on the fee record Ended Nov 17, 2021 · USPTO record | Lapsed on the fee record | Ended Nov 17, 2021 | USPTO record |
| US 9,149,514 | Composition and method for treating papilloma virus and equine sarcoids Formerly held Lapsed on the fee record Ended Oct 6, 2019 · USPTO record | Lapsed on the fee record | Ended Oct 6, 2019 | USPTO record |
| US 7,846,430 | Composition and method for treating bovine papilloma virus in equine Formerly held Lapsed on the fee record Ended Dec 7, 2014 · USPTO record | Lapsed on the fee record | Ended Dec 7, 2014 | USPTO record |